Your browser doesn't support javascript.
loading
BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish population.
Debniak, Tadeusz; Scott, Rodney J; Górski, Bohdan; Masojc, Bartlomiej; Kram, Andrzej; Maleszka, Romuald; Cybulski, Cezary; Paszkowska-Szczur, Katarzyna; Kashyap, Aniruddh; Murawa, Dawid; Malinska, Karolina; Kiedrowicz, Magdalena; Rogoza-Janiszewska, Emilia; Rudnicka, Helena; Deptula, Jakub; Domagala, Pawel; Kluzniak, Wojciech; Lener, Marcin R; Lubinski, Jan.
Afiliação
  • Debniak T; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Scott RJ; School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle and the Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • Górski B; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Masojc B; West Pomeranian Oncology Center, Szczecin, Poland.
  • Kram A; West Pomeranian Oncology Center, Szczecin, Poland.
  • Maleszka R; Department of Skin Diseases and Venerology PUM, Police, Poland.
  • Cybulski C; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Paszkowska-Szczur K; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kashyap A; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Murawa D; I Department of Oncological and General Surgery, Greater Poland Cancer Center, Poznan, Poland.
  • Malinska K; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kiedrowicz M; Department of Skin Diseases and Venerology PUM, Police, Poland.
  • Rogoza-Janiszewska E; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Rudnicka H; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Deptula J; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Domagala P; Department of Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kluzniak W; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Lener MR; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Lubinski J; Department of Genetics and Pathomorphology, International Hereditary Cancer Center, Pomeranian Medical University in Szczecin, Szczecin, Poland.
PLoS One ; 13(10): e0204768, 2018.
Article em En | MEDLINE | ID: mdl-30286154
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Melanoma / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína BRCA1 / Predisposição Genética para Doença / Proteína BRCA2 / Melanoma / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Polônia País de publicação: Estados Unidos